Advertisement
Screener

Johnson & Johnson (JNJ) Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31)

Johnson & Johnson Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31)

Johnson & Johnson (JNJ) reported Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) of $94.00 million for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-09.

Discontinued › Income Statement › Unrealized Gains

us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease · last filed 2012-11-09

  • Johnson & Johnson other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for the quarter ending 2012-09-30 was $94.00M, a 28.77% increase year-over-year.
  • Johnson & Johnson other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for the quarter ending 2012-07-01 was $95.00M, a 69.64% increase year-over-year.
  • Johnson & Johnson other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for the quarter ending 2012-04-01 was $94.00M, a 30.56% increase year-over-year.
  • Johnson & Johnson other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for the quarter ending 2012-01-01 was -$1.90B.
  • Johnson & Johnson other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for fiscal 2012 was -$1.70B.
  • Johnson & Johnson other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for fiscal 2011 was -$21.00M, a 103.72% decline from fiscal 2010.
  • Johnson & Johnson other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for fiscal 2010 was $565.00M.
  • Johnson & Johnson other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for fiscal 2008 was -$1.87B, a 379.10% decline from fiscal 2007.
Period endOther Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) 3 monthOther Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) 6 monthOther Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) 9 monthOther Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) 12 month
2012-09-30$94.00M
10-Q · filed 2012-11-09
$189.00M
derived: sum of 2 quarters · filed 2012-11-09
$283.00M
10-Q · filed 2012-11-09
-$1.62B
derived: sum of 4 quarters · filed 2012-11-09
2012-07-01$95.00M
10-Q · filed 2012-08-02
$189.00M
10-Q · filed 2012-08-02
-$1.71B
derived: sum of 3 quarters · filed 2012-08-02
-$1.64B
derived: sum of 4 quarters · filed 2012-11-09
2012-04-01$94.00M
10-Q · filed 2012-05-07
-$1.81B
derived: sum of 2 quarters · filed 2012-05-07
-$1.73B
derived: sum of 3 quarters · filed 2012-11-09
-$1.68B
derived: sum of 4 quarters · filed 2012-11-09
2012-01-01-$1.90B
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23
-$1.83B
derived: sum of 2 quarters · filed 2012-11-09
-$1.77B
derived: sum of 3 quarters · filed 2012-11-09
-$1.70B
10-K · filed 2012-02-23
2011-10-02$73.00M
10-Q · filed 2012-11-09
$129.00M
derived: sum of 2 quarters · filed 2012-11-09
$201.00M
10-Q · filed 2012-11-09
2011-07-03$56.00M
10-Q · filed 2012-08-02
$128.00M
10-Q · filed 2012-08-02
2011-04-03$72.00M
10-Q · filed 2012-05-07
2011-01-02-$21.00M
10-K · filed 2012-02-23
2010-01-03$565.00M
10-K · filed 2012-02-23
2008-12-28-$1.87B
10-K · filed 2011-02-25
2007-12-30$670.00M
10-K · filed 2010-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
AbbVie Inc. (ABBV)United States$468.180B70.37
Merck & Co., Inc. (MRK)United States$365.215B99.96
ELI LILLY & Co (LLY)United States$1,113.804B42.28
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38